H. Hayashi et al., Protective effects of sialyl Lewis X and anti-P-selectin antibody against lipopolysaccharide-induced acute lung injury in rabbits, EUR J PHARM, 370(1), 1999, pp. 47-56
The prophylactic effects of selectin inhibitors on lipopolysaccharide-induc
ed acute lung injury were studied in rabbits by using sialyl Lewis X-oligos
accharide and PB1.3, an anti-human P-selectin monoclonal antibody. Lipopoly
saccharide-induced acute lung injury resembles that of the acute respirator
y distress syndrome, in which there is a decrease in arterial blood oxygen
tension (PaO2) and an increase in the difference between alveolar and arter
ial oxygen tension (A-aDO(2)). Prophylactic treatment with the selectin inh
ibitors, sialyl Lewis X-oligosaccharide (55 mg kg(-1) i.v. bolus injection
immediately before lipopolysaccharide administration + 36 mg kg(-1) h(-1) i
.v. infusion for 4 h) and PB1.3 (5 mg kg(-1) i.v. bolus injection immediate
ly before lipopolysaccharide administration), prevented the lipopolysacchar
ide-induced impairments in pulmonary gas exchange. In contrast, these agent
s had no significant effects on lipopolysaccharide-induced systemic hypoten
sion, the decrease in the number of circulating white blood cells and plate
lets, the decline in blood pH, or the increase in arterial CO2 tension (PaC
O2). These results indicate that selectin inhibitors including sialyl Lewis
X-oligosaccharide and the anti-P-selectin antibody, PB1.3, attenuate lipop
olysaccharide-induced acute lung injury in rabbits. This is the first demon
stration that P-selectin is directly involved in the development of lipopol
ysaccharide-induced impairments in pulmonary gas exchange. (C) 1999 Elsevie
r Science B.V. All rights reserved.